Realtime AI News
Voyage Labs raises $12M seed to build a travel-only AI assistant
Voyage Labs, founded by former Google Maps and Uber product executive Manik Gupta, has raised $12 million in seed funding led by Kleiner Perkins, with SignalFire and SV Angel participating. The money will go toward supplier partnerships and engineering headcount behind Atlas, a travel assistant now in private beta.

Trip planning has become the default demo for personal AI assistants: Muse does it, Gemini does it, and half a dozen other products do it too. Most of those pitches treat travel as one showcase for a general-purpose agent. Voyage Labs is betting the opposite way, that travel deserves a product built only for travel.
The startup, founded by a Google Maps veteran, announced $12 million in seed funding on Tuesday, led by Kleiner Perkins with participation from SignalFire and SV Angel. According to TechCrunch, the money will go toward expanding supplier partnerships and growing the engineering team.
Its flagship product is Atlas, positioned as an always-on personal assistant for an entire trip and available today in private beta. Co-founder and CEO Manik Gupta describes it as covering the whole journey, from the moment someone has an idea for a trip to the moment they get home, including planning, booking and managing the reservation.
Rather than generating an itinerary once, Atlas is built to stay in the conversation for weeks: fielding ideas, researching each one, and tailoring recommendations based on a long-running dialogue while monitoring real-time price changes and eventually booking flights and hotels.
Co-founder and CTO Yogesh Jain frames that as a fit between task shape and technology. Trip planning is a project with its own lifecycle that unfolds across days and weeks, which makes long-running agents a natural match.
The team's experience is the main argument. Gupta spent years as director of product management for Google Maps and then four years as chief product officer at Uber; by his account, his only job for eight years was to wake up and go build the map.
Competition is the open question. Frontier labs keep folding travel into general assistants, and it is not yet clear that a specialized product wins on experience. Gupta's view is that the space is still changing fast and nobody can be certain which form factors will thrive.
The bet is that travel and the outdoors are large enough to support a focused product, and that stitching the fragments into one end-to-end experience is itself the moat. What to watch next is how deep the supplier partnerships go, whether Atlas scales beyond private beta, and whether users hand over an entire trip to a dedicated agent.
Why it matters
It shows the assistant race shifting from general capability toward vertical workflows, with seed capital betting on deep supplier integration as the differentiator. The test is whether a dedicated agent can hold its own against travel features inside frontier-lab assistants.
Nearby Updates
All11/17, 23:00
ExpertFile launches ProfileIQ, an AI agent that drafts expert profiles for search and AI citation
ExpertFile has launched ProfileIQ, an AI agent that cross-checks multiple sources to draft expert profiles with topic tags, schema markup, ORCID matching and a human review step. It is available now and included for all ExpertFile clients, aimed at making institutional experts discoverable by AI answer engines.
11/17, 22:58
Plaid launches Agent Detection to tell humans from AI agents in finance
Plaid has launched Agent Detection, a product that tells banks and fintechs whether a financial interaction is driven by a human or an AI agent, and which AI provider the agent belongs to. In live-traffic tests the company says it flagged 2.3 times more agent sessions than competing tools without more false positives.
11/17, 22:50
Isomorphic Labs raises $5B Series C to push drug candidates toward clinical trials
Isomorphic Labs, the AI drug-discovery company spun out of Google DeepMind, has raised $5 billion in a Series C round co-led by Greenoaks and Sequoia Capital. The company says its programs have shown positive preclinical results in oncology and immunology, and the new capital will help push candidates toward clinical trials.
11/17, 22:05
Nvidia Forms Board National Security Committee to Oversee Export Controls
Nvidia has created a standing board committee with direct oversight of national security policy, export control compliance and global trade risk, meeting at least quarterly. Announced hours before the company's third-quarter earnings call, it is interim CEO Colette Kress's first major action, taken amid congressional scrutiny of Jensen Huang and U.S. chip export policy.